Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage
NCT00375258
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20211
Enrollment
OTHER
Sponsor class
Conditions
Hemorrhage
Interventions
DRUG:
Tranexamic acid
DRUG:
Sodium Chloride 0.9%
Sponsor
London School of Hygiene and Tropical Medicine